Therapeutic Targeting of Decr1 Ameliorates Cardiomyopathy by Suppressing Mitochondrial Fatty Acid Oxidation in Diabetic Mice

ABSTRACT Background A significant increase in mitochondrial fatty acid oxidation (FAO) is now increasingly recognized as one of the metabolic alterations in diabetic cardiomyopathy (DCM). However, the molecular mechanisms underlying mitochondrial FAO impairment in DCM remain to be fully elucidated....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Qing‐Bo Lu, He‐Ting Sun, Kuo Zhou, Jia‐Bao Su, Xin‐Yu Meng, Guo Chen, Ao‐Yuan Zhang, An‐Jing Xu, Chen‐Yang Zhao, Yuan Zhang, Yao Wang, Hong‐Bo Qiu, Zhuo‐Lin Lv, Zheng‐Yang Bao, Jian Zhu, Feng Xiao, Xue‐Xue Zhu, Hai‐Jian Sun
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-04-01
Colecção:	Journal of Cachexia, Sarcopenia and Muscle
Assuntos:	cardiomyopathy Decr1 diabetes fatty acid oxidation oxidative stress PDK4
Acesso em linha:	https://doi.org/10.1002/jcsm.13761
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!